An automated flinch detecting system for use in the formalin nociceptive bioassay

Journal of Applied Physiology

Volumn 90, Issue 6, 2001, Pages 2386-2402

  Yaksh, Tony L ^a,c   Ozaki, George ^a   McCumber, Damon ^a   Rathbun, Michael ^a   Svensson, Camilla ^a   Malkmus, Shelle ^a   Yaksh, Michael C ^b  

^a University of California   (United States)

^b Yaksh Magnetic Solutions   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Flinching behavior; Formalin test; Pain models; Spinal sensitization

Indexed keywords

DIZOCILPINE; FORMALDE FRESH; FORMALDEHYDE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; ELECTROMAGNETIC FIELD; FEMALE; MALE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SIGNAL PROCESSING;

EID: 0035000170     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.2001.90.6.2386     Document Type: Article

References (52)

1. Abbadie C, Taylor BK, Peterson MA, and Basbaum AI. Differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: studies with remifentanil and lidocaine. Pain 69: 101-110, 1997.
2. Abbott FV, Franklin KB, and Westbrook RF. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 60: 91-102, 1995.
3. Abram SE and Yaksh TL. Morphine, but not inhalation anesthesia, blocks post-injury facilitation. The role of preemptive suppression of afferent transmission. Anesthesiology 78: 713-721, 1993.
4. Abram SE and Yaksh TL. Systemic lidocaine blocks nerve injury-induced hyperalgesia and nociceptor-driven spinal sensitization in the rat. Anesthesiology 80: 383-391, 25A, 1994.
5. Aloisi AM, Albonetti ME, and Carli G. Behavioural effects of different intensities of formalin pain in rats. Physiol Behav 58: 603-610, 1995.
6. Bannon AW, Decker MW, Curzon P, Buckley MJ, Kim DJ, Radek RJ, Lynch JK, Wasicak JT, Lin NH, Arnold WH, Holladay MW, Williams M, and Arneric SP. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors. II. In vivo characterization. J Pharmacol Exp Ther 285: 787-794, 1998.
7. Bhatnagar S, Dallman MF, Roderick RE, Basbaum AI, and Taylor BK. The effects of prior chronic stress on cardiovascular responses to acute restraint and formalin injection. Brain Res 797: 313-320, 1998.
8. Brennan TJ. AMPA/kainate receptor antagonists as novel analgesic agents. Anesthesiology 89: 1049-1051, 1998.
9. Buerkle H, Marsala M, and Yaksh TL. Effect of continuous spinal remifentanil infusion on behaviour and spinal glutamate release evoked by subcutaneous formalin in the rat. Br J Anaesth 80: 348-353, 1998.
10. Chaplan SR, Malmberg AB, and Yaksh TL. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther 280: 829-838, 1997.
11. Clavelou P, Dallel R, Orliaguet T, Woda A, and Raboisson P. The orofacial formalin test in rats: effects of different formalin concentrations. Pain 62: 295-301, 1995.
12. Coderre TJ, Fundytus ME, McKenna JE, Dalal S, and Melzack R. The formalin test: a validation of the weighted-scores method of behavioural pain rating. Pain 54: 43-50, 1993.
13. Dallel R, Raboisson P, Clavelou P, Saade M, and Woda A. Evidence for a peripheral origin of the tonic nociceptive response to subcutaneous formalin. Pain 61: 11-16, 1995.
14. Dickenson AH, Stanfa LC, Chapman V, and Yaksh TL. Response properties of dorsal horn neurons: pharmacology of the dorsal horn. In: Anesthesia: Biologic Foundations, edited by Yaksh TL, Lynch C III, Zapol WM, Maze M, Biebuyck JF, and Saidman LJ. Philadelphia, PA: Lippincott-Raven, 1997, p. 611-624.
15. Dickenson AH and Sullivan AF. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurons. Neurosci Lett 83: 207-211, 1987.
16. Dirig DM and Yaksh TL. Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J Pharmacol Exp Ther 275: 219-227, 1995.
17. Dray A and Dickenson A. Systemic capsaicin and olvanil reduce the acute algogenic and the late inflammatory phase following formalin injection into rodent paw. Pain 47: 79-83, 1991.
18. Dubuisson D and Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161-174, 1977.
19. Handwerker HO. Electrophysiological mechanisms in inflammatory pain. Agents Actions Suppl 32: 91-99, 1991.
20. Hunter JC and Singh L. Role of excitatory amino acid receptors in the mediation of the nociceptive response to formalin in the rat. Neurosci Lett 174: 217-221, 1994.
21. Jett MF and Michelson S. The formalin test in rat: validation of an automated system. Pain 64: 19-25, 1996.
22. Jourdan D, Ardid D, Bardin L, Bardin M, Neuzeret D, Lanphouthacoul L, and Eschalier A. A new automated method of pain scoring in the formalin test in rats. Pain 71: 265-270, 1997.
23. Malmberg AB, Rafferty MF, and Yaksh TL. Antinociceptive effect of spinally delivered prostaglandin E receptor antagonists in the formalin test on the rat. Neurosci Lett 173: 193-196, 1994.
24. Malmberg AB and Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 263: 136-146, 1992.
25. Malmberg AB and Yaksh TL. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 79: 270-281, 1993.
26. Malmberg AB and Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 54: 291-300, 1993.
27. Malmberg AB and Yaksh TL. Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hotplate tests in rats. Pain 60: 83-90, 1995.
28. Nozaki-Taguchi N and Yaksh TL. A novel model of primary and secondary hyperalgesia after mild thermal injury in the rat. Neurosci Lett 254: 25-28, 1998.
29. Peterson MA, Basbaum AI, Abbadie C, Rohde DS, McKay WR, and Taylor BK. The differential contribution of capsaicin-sensitive afferents to behavioral and cardiovascular measures of brief and persistent nociception and to Fos expression in the formalin test. Brain Res 755: 9-16, 1997.
30. Prado WA and Goncalves AS. Antinociceptive effect of intrathecal neostigmine evaluated in rats by two different pain models. Braz J Med Biol Res 30: 1225-1231, 1997.
31. Price DD, Bennett GJ, and Rafii A. Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block. Pain 36: 273-288, 1989.
32. Puig S and Sorkin LS. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 64: 345-355, 1996.
33. Raboisson P, Dallel R, Clavelou P, Sessle BJ, and Woda A. Effects of subcutaneous formalin on the activity of trigeminal brain stem nociceptive neurones in the rat. J Neurol 73: 496-505, 1995.
34. Shimoyama N, Shimoyama M, Davis AM, Inturrisi CE, and Elliott KJ. Spinal gabapentin is antinociceptive in the rat formalin test. Neurosci Lett 222: 65-67, 1997.
35. Simmons RM, Li DL, Hoo KH, Deverill M, Ornstein PL, and Iyengar S. Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology 37: 25-36, 1998.
36. Singh L, Field MJ, Ferris P, Hunter JC, Oles RJ, Williams RG, and Woodruff GN. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology (Berl) 127: 1-9, 1996.
37. Tallarida RJ and Murray RB. Manual of Pharmacologic Calculations With Computer Programs (2nd ed.). New York: Springer-Verlag, 1987, p. 291.
38. Taylor BK, Akana SF, Peterson MA, Dallman MF, and Basbaum AI. Pituitary-adrenocortical responses to persistent noxious stimuli in the awake rat: endogenous corticosterone does not reduce nociception in the formalin test. Endocrinology 139: 2407-2413, 1998.
39. Taylor BK, Peterson MA, and Basbaum AI. Persistent cardiovascular and behavioral nociceptive responses to subcutaneous formalin require peripheral nerve input. J Neurol 15: 7575-7584, 1995.
40. Taylor BK, Peterson MA, and Basbaum AI. Early nociceptive events influence the temporal profile, but not the magnitude, of the tonic response to subcutaneous formalin: effects with remifentanil. J Pharmacol Exp Ther 280: 876-883, 1997.
41. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, and Hole K. The formalin test: an evaluation of the method. Pain 51: 5-17, 1992.
42. Wheeler-Aceto H and Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology (Berl) 104: 35-44, 1991.
43. Wheeler-Aceto H, Porreca F, and Cowan A. The rat paw formalin test: comparison of noxious agents. Pain 40: 229-238, 1990.
44. Woolf CJ. Long term alterations in the excitability of the flexion reflex produced by peripheral tissue injury in the chronic decerebrate rat. Pain 18: 325-343, 1984.
45. Yaksh TL. Preclinical models of nociception. In: Anesthesia: Biologic Foundations, edited by Yaksh TL, Lynch C III, Zapol WM, Maze M, Biebuyck JF, and Saidman LJ. Philadelphia, PA: Lippincott-Raven, 1997, vol. I, p. 685-718.
46. Yaksh TL, Farb DH, Leeman SE, and Jessell TM. Intrathecal capsaicin depletes substance P in the rat spinal cord and produces prolonged thermal analgesia. Science 206: 481-483, 1979.
47. Yaksh TL, Hua XY, Kalcheva I, Nozaki-Taguchi N, and Marsala M. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci USA 96: 7680-7686, 1999.
48. Yaksh TL and Malmberg AB. Central pharmacology of nociceptive transmission. In: Textbook of Pain (4th ed.), edited by Wall P and Melzack R. Edinburgh, UK: Churchill Livingstone, 1999, p. 253-308.
49. Yaksh TL and Rudy TA. Chronic catheterization of the spinal sub-arachnoid space. Physiol Behav 17: 1031-1036, 1976.
50. Yamamoto T and Yaksh TL. Stereospecific effects of a non-peptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Sci 49: 1955-1963, 1991.
51. Yoon MH and Yaksh TL. The effect of intrathecal gabapentin on pain behavior and hemodynamics on the formalin test in the rat. Anesth Analg 89: 434-439, 1999.
52. Zar JH. Biostatistical Analysis (2nd ed.). Englewood Cliffs, NJ: Prentice-Hall, 1984.